News from our business units
New regulatory requirements are increasing the demands placed on digital sovereignty. Resilience is becoming mandatory.
AI in the regulated GxP environment: Dr Hans Klöcker explains how pharmaceutical companies validate AI solutions and ensure safe, compliant operation.
Transformation Insights
New regulatory requirements are increasing the demands placed on digital sovereignty. Resilience is becoming mandatory.
AI in the regulated GxP environment: Dr Hans Klöcker explains how pharmaceutical companies validate AI solutions and ensure safe, compliant operation.
Neue Artikel
Pharmaceutical companies have poured significant resources into CRM systems, master data management, compliance, and data protection over the past several years. Most organizations now have more data than ever.
AI validation in GxP requires a shift from static CSV to a lifecycle-based approach with continuous monitoring. This is essential to ensure quality, safety, and compliance in non-deterministic systems.